1 | AIMP2, SNCA
|
| Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
|
| Ham S, Yun SP, Kim H, Kim D, Seo BA, Kim H, Shin JY, Dar MA, Lee GH, Lee YI, Kim D, Kim S, Kweon HS, Shin JH, Ko HS, Lee Y.
|
| Sci Transl Med. Nov 11;12(569):eaax0091. doi: 10.1126/scitranslmed.aax0091. 2020
|
2 | AIMP2
|
| Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer
|
| Ku J, Kim R, Kim D, Kim D, Song S, Lee K, Lee N, Kim M, Yoon SS, Kwon NH, Kim S, Kim Y, Koh Y.
|
| Commun Biol. Oct 30;3(1):630. doi: 10.1038/s42003-020-01353-x. 2020
|
3 | AIMP2, HLD17
|
| Homozygosity for a nonsense variant in AIMP2 is associated with a progressive neurodevelopmental disorder with microcephaly, seizures, and spastic quadriparesis.
|
| Shukla A, Das Bhowmik A, Hebbar M, Rajagopal KV, Girisha KM, Gupta N, Dalal A.
|
| J Hum Genet. Jan;63(1):19-25. doi: 10.1038/s10038-017-0363-1. Epub 2017 Nov 16. 2018
|
4 | AIMP2
|
| Purification and biophysical characterization of the AIMP2-DX2 protein.
|
| Jha R, Cho HY, Mushtaq AU, Lee K, Kim DG, Kim S, Jeon YH.
|
| Protein Expr Purif. Apr;132:131-137. doi: 10.1016/j.pep.2017.02.002. Epub 2017 Feb 7. 2017
|
5 | AIMP2, VPS35
|
| VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
|
| Yun SP, Kim H, Ham S, Kwon SH, Lee GH, Shin JH, Lee SH, Ko HS, Lee Y.
|
| Cell Death Dis. Apr 6;8(4):e2741. doi: 10.1038/cddis.2017.157. 2017
|
6 | AIMP2
|
| AIMP2 Controls Intestinal Stem Cell Compartments and Tumorigenesis by Modulating Wnt/β-Catenin Signaling
|
| Yum MK, Kang JS, Lee AE, Jo YW, Seo JY, Kim HA, Kim YY, Seong J, Lee EB, Kim JH, Han JM, Kim S, Kong YY.
|
| Cancer Res. Aug 1;76(15):4559-68. doi: 10.1158/0008-5472.CAN-15-3357. Epub 2016 Jun 4. 2016
|
7 | AIMP2
|
| Structural switch of lysyl-tRNA synthetase between translation and transcription.
|
| Ofir-Birin Y, Fang P, Bennett SP, Zhang HM, Wang J, Rachmin I, Shapiro R, Song J, Dagan A, Pozo J, Kim S, Marshall AG, Schimmel P, Yang XL, Nechushtan H, Razin E, Guo M.
|
| Mol Cell. Jan 10;49(1):30-42. doi: 10.1016/j.molcel.2012.10.010. Epub 2012 Nov 15. 2013
|
8 | AIMP2
|
| Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer
|
| Choi JW, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S.
|
| J Mol Cell Biol. Jun;4(3):164-73. doi: 10.1093/jmcb/mjs018. Epub 2012 Apr 24. 2012
|
9 | ABL1, AIMP2, FBP1, PRKN
|
| Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
|
| Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM.
|
| Proc Natl Acad Sci U S A 107(38):16691-6. Epub 2010 Sep 7. 2010
|
10 | AIMP2
|
| AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53.
|
| Han JM, Park BJ, Park SG, Oh YS, Choi SJ, Lee SW, Hwang SK, Chang SH, Cho MH, Kim S.
|
| Proc Natl Acad Sci U S A 105(32):11206-11. Epub 2008 Aug 11. 2008
|
11 | AIMP2
|
| Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers.
|
| Park SG, Ewalt KL, Kim S.
|
| Trends Biochem Sci 30(10):569-74. Review. 2005
|
12 | AIMP2, EPRS
|
| Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation.
|
| Sampath P, Mazumder B, Seshadri V, Gerber CA, Chavatte L, Kinter M, Ting SM, Dignam JD, Kim S, Driscoll DM, Fox PL.
|
| Cell 119(2):195-208. 2004
|
13 | AIMP2, PMS2
|
| Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene.
|
| Nicolaides NC, et al.
|
| Genomics 29 : 329-334. 1995
|